ArticleJCI insight2021

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine.

Roland Tschismarov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.